PenderFund Capital Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

PenderFund Capital Management’s Portfolio ZYNE Stock Details ZYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-123,444	Closed	-$213K	–	150
2023 Q3	$213K	Buy	+123,444	New	+$108K	0.06%	93

PenderFund Capital Management's ZYNE Position: Q4 2023 in Review

PenderFund Capital Management sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q4 2023, closing a stake of 123,444 shares — an estimated $213K sold.

PenderFund Capital Management first reported a position in ZYNE in Q3 2023 and held it in 1 quarter. The position peaked at $213K in Q3 2023. 0 funds tracked by Wall St. Rank hold ZYNE as of Q4 2023.

PenderFund Capital Management reported no remaining Zynerba Pharmaceuticals, Inc position as of Q4 2023 after selling out during the quarter.
PenderFund Capital Management sold 123,444 Zynerba Pharmaceuticals, Inc shares in Q4 2023, an estimated $213K.
PenderFund Capital Management first reported a position in Zynerba Pharmaceuticals, Inc in Q3 2023 and held it in 1 quarter.
PenderFund Capital Management's Zynerba Pharmaceuticals, Inc position peaked at $213K in Q3 2023.
0 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q4 2023.

Based on PenderFund Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.